B-Cell disorders and curcumin

Authors

Terry Golombick, St. George HospitalFollow
Terrence H. Diamond, St. George HospitalFollow
Arumugam Manoharan, University of WollongongFollow
Raj Ramakrishna, University of WollongongFollow

RIS ID

107643

Publication Details

Golombick, T., Diamond, T. H., Manoharan, A. & Ramakrishna, R. (2017). B-Cell disorders and curcumin. Integrative Cancer Therapies, 16 (3), 255-257.

Abstract

Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.